GLP1 NAION warning: FDA orders class-wide labels for potential rare eye risk

Punten die meer dan één medium meldde

1. FDA requirement for NAION warnings on GLP-1 labels3 media
2. NAION effects on vision2 media
3. Drugs covered by the FDA labeling requirement2 media
4. Evidence included in the FDA evaluation2 media